Hubei health commission coerces public hospitals into procuring favored local drugs through illegal quota directives
- Hubei Provincial Health Commission issued confidential procurement directives forcing public hospitals to replace clinically proven medications with local state-owned drug brands.
- Hospital directors who resisted quotas faced disciplinary audits and budget reductions.
- Highlights regional economic protectionism compromising patient health outcomes to boost municipal tax receipts.
Provincial bureaucrats in Hubei decided which medicines doctors were allowed to prescribe. The Hubei Provincial Health Commission established an illegal preferential catalog protecting twenty-six favored local pharmaceutical companies, Phoenix News reported. Commissars forced all secondary and tertiary public hospitals to buy local drugs, monitoring hospital pharmacy ledgers in real time and threatening directors with demotions if they prescribed better medicines made outside the province.
The order is a brazen example of bureaucratic protectionist cartels operating through administrative coercion. It undermines national healthcare procurement reforms enacted in 2018. Provincial health officials built a state-enforced sales monopoly, deliberately subordinating clinical autonomy to municipal tax revenues. Hospital chiefs were forced to treat state wards as captive customers for politically connected drugmakers, regardless of treatment efficacy.
The directive shows how public health is sacrificed to departmental self-interest. In a system without independent regulators, transparent bidding, or patient advocacy, ordinary sick people have no voice. Patients are denied the most effective treatments simply because a provincial cadre needed to hit a local tax quota.
Physicians on medical forum DXY (丁香园) voiced quiet despair: 'Doctors are forced to prescribe inferior local pharmaceutical formulas just so regional cadres hit provincial GDP quotas.'
Hubei provincial health commission issued urgent internal notices barring hospital staff from leaking procurement quotas to journalists.
Local protectionism (地方保护主义) in China's drug supply chain often forces tertiary hospitals to replace proven national medications with unproven local SOE products.